title: Ultrastructure of an arterial lesion induced in rats by fenoldopam mesylate, a dopaminergic vasodilator.
abstract: Fenoldopam mesylate (FM) is a dopaminergic vasodilator with demonstrated efficacy and a favourable safety profile in hypertensive and congestive heart failure patients. FM produced a novel arterial lesion in renal and splanchnic arteries of rats, but not dogs or monkeys. The studies reported here were undertaken to investigate the ultrastructure of the arterial lesion induced in rats by FM in an attempt to shed light on its pathogenesis. Rats were infused intravenously with FM, either 50 micrograms/kg/min for 1 or 4 h, or 5 or 100 micrograms/kg/min for 24 h. Control rats were infused for 4 or 24 h with vehicle alone. Perfusion-fixed tissue from the stomach and pancreas of control and drug-treated rats was examined by transmission electron microscopy. No arterial lesions were seen in rats infused with the drug for 1 or 4 h, or in control rats. All drug-treated rats infused with 5 or 100 micrograms/kg/min of FM for 24 h had lesions in subserosal gastric arteries and interlobular pancreatic arteries. In areas of mild arterial damage, medial smooth muscle cells contained intracytoplasmic pseudovacuoles, autophagic vacuoles, and electron-dense, myofilamentous inclusions. More severe lesions were characterized by overt medial necrosis and haemorrhage. The endothelium of affected arteries was invariably intact, except in areas of severe medial damage. The internal elastic lamina and connective tissue elements within the arterial wall were unaffected. These findings suggest that medial smooth muscle cells are the primary site of damage caused by fenoldopam mesylate in splanchnic arteries of the rat. This iatrogenic arterial lesion could provide an interesting model to study the response of medial smooth muscle to pharmacologically mediated injury.
authors.affiliation: Department of Experimental Pathology, Smith Kline & French Laboratories, Philadelphia, PA 19101.
authors.forename: P J
authors.initials: PJ
authors.lastname: Bugelski
authors.forename: C M
authors.initials: CM
authors.lastname: Vockley
authors.forename: J M
authors.initials: JM
authors.lastname: Sowinski
authors.forename: E
authors.initials: E
authors.lastname: Arena
authors.forename: B A
authors.initials: BA
authors.lastname: Berkowitz
authors.forename: D G
authors.initials: DG
authors.lastname: Morgan
mesh_terms: D000818:Animals; D001158:Arteries / Q000187:drug effects / Q000473:pathology; D001552:Benzazepines / Q000008:administration & dosage / Q000494:pharmacology*; D001794:Blood Pressure; D018818:Fenoldopam; D007262:Infusions, Intravenous; D008297:Male; D008854:Microscopy, Electron; D009336:Necrosis / Q000139:chemically induced*; D051381:Rats; D011919:Rats, Inbred Strains; D013152:Splanchnic Circulation; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D001552:Benzazepines; D014665:Vasodilator Agents; D018818:Fenoldopam